v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04332094 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
pdomingo@santpau.cat |
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-04-02 |
Recruitment status
Last imported at : May 8, 2023, midnight Source : ClinicalTrials.gov |
Unknown |
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : May 8, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
inclusion criteria: - subject (or authorized legal representative) who can provide written informed consent before beginning any study procedure. - understand and agree to abide by the study procedures. - adult #18 years of age at the time of inclusion in the study. - confirmation of sars-cov-2 infection by a microbiological test performed before randomization, no longer than 72 hours. - severity 3-4 according to the who 7-point ordinal scale. |
Exclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
- alt / ast> 5 times the normal limit - stage 4 chronic kidney disease (gfr <30) or requiring dialysis. - presence of comorbidities that imply a poor prognosis (according to clinical judgment). - advanced dementia. - pregnancy or breastfeeding. - anticipation of transfer to another center in the 12 hours at the beginning of the study. - allergy to study medication. - serious or active bacterial infections or documented sepsis by pathogens other than sars-cov-2. - streptococcus pneumoniae antigenuria positive before study start. - neutropenia <500 / mm3. - thrombocytopenia <100,000 / mm3. - history of diverticulosis. - ongoing skin infection (eg, pyodermitis). - transplanted patient under immunosuppressive treatment. - previous evidence of latent untreated tuberculosis. |
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
FundaciĆ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Countries
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Spain |
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Mild disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
1: Mild disease at enrollment |
Total sample size
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
276 |
primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Need for mechanical ventilation in the Intensive Care Unit;In-hospital mortality |
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m. Source : ClinicalTrials.gov |
Phase 2 |
Arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1534, "treatment_name": "Azithromycin+hydroxychloroquine", "treatment_type": "Antibiotics+antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1425, "treatment_name": "Azithromycin+hydroxychloroquine+tocilizumab", "treatment_type": "Antibiotics+antimalarials+interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}] |